Rathindra N. Bose and Evelyne L. Weaver
A long-lived ascorbate radical was characterized during the reduction of a series of platinum(IV) antitumor drugs; ascorbate reductions proceed through a platinum(IV)–ascorbate intermediate, the formation of which is catalysed by platinum(II).